VentriPoint Diagnostics (TSE:VPT) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ventripoint Diagnostics has successfully closed debt settlement agreements by issuing 128,900 common shares to settle $19,335 of debt owed to a former director and their holding company. This strategic move allows Ventripoint to conserve cash for future business development. The shares issued as part of this transaction are subject to approval by the TSX Venture Exchange.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.